| Phase 1 1985-88 | Phase 3 91-93 | Phase 5 97-99 | Phase 7 03-04 | Phase 9 07-09 | Phase 11 12-13 |
---|---|---|---|---|---|---|
Ages [years] | 35-55 | 39-64 | 45-69 | 50-74 | 55-79 | 60-85 |
Participants [n] | 10308 | 8637 | 7830 | 6967 | 6755 | 6035 |
Social circumstances & behaviour, smoking, alcohol, exercise, sleep diet | × | × | × | × | × | × |
Biological measures: blood pressure, BMI, lipids, glucose, insulin, stored blood (−80C) | × | × | × | × | × | × |
2-h oral glucose tolerance test | -- | × | × | × | × | × |
Inflammatory markers | -- | × | × | × | × | -- |
Autonomic (HRV) | -- | -- | × | × | × | × |
Genetic material | -- | -- | -- | × | × | × |
Psychosocial factors: work, social support, − participation, care provision | × | × | × | × | × | × |
Health outcomes: CHD, stroke, diabetes, cancer, mortality, medications | × | × | × | × | × | × |
Function: physical, social & mental | × | × | × | × | × | × |
Cognitive tests, physical/lung function tests | -- | -- | × | × | × | × |